
Description:
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic analog of growth hormone releasing hormone (GHRH) studied for its role in sustained growth hormone secretion and IGF-1 pathway regulation. The addition of the Drug Affinity Complex extends the half-life of the peptide by enabling albumin binding, supporting prolonged GH pulse stimulation in research models. Preclinical research has explored its effects on GH and IGF-1 elevation, lean body composition, metabolic regulation, and age-related GH decline across controlled in-vitro and in-vivo research models.
The lyophilized preparation enables accurate laboratory reconstitution using sterile handling techniques. Consistent preparation methods and appropriate storage conditions help maintain compound stability and improve reproducibility during extended research cycles.
Product Specifications
For research purposes only. Not for human or animal use & not FDA-approved. By purchasing, you confirm you are 21 or older and a qualified researcher.
